Genky DrugStores Co., Ltd.
Notice on Granted Stock Options (Stock Acquisition Rights)
The board resolved to grant stock acquisition rights under particularly favorable terms to internal directors, employees, and directors/employees of subsidiaries. The total grant cap is 1,500 rights, with 100 shares per right, and the issuance date is assumed to be September 10, 2026. The exercise price is the closing price multiplied by 1.05, rounded up, with adjustments for stock splits, consolidations, and capital reductions.
Key Figures
- Total number of stock acquisition rights: capped at 1,500 units
- Number of granted shares: 100 shares per unit
- Total upper limit of shares under stock acquisition rights: 150,000 shares
AI要約
Purpose and target of stock option grant
The Board resolved to present for resolution at this general meeting the募集事項 to have internal directors, employees, and directors/employees of subsidiaries acquire stock options under particularly favorable terms. The grant of stock options is intended as an employee compensation measure to improve group performance and morale.
Overview of grant content and conditions
Targets are internal directors, employees, and directors/employees of subsidiaries. The total cap is 1,500 rights, with 100 shares issued per right. Multiple adjustment provisions are established, including adjustments for stock splits and consolidations, adjustments for capital reductions, and exercise price calculation (average of closing prices × 1.05, rounded up). The exercise period is set from two years after the resolution date to within five years.
Genky DrugStores Co., Ltd.
Company overview · Stock price · Financial data · All IR
